Form D · Other
Humaneva, Inc.
Raleigh, NC · CIK 0002040865
Offering snapshot reported Oct 10, 2024 · SEC filing
- Reported sold
- $50M Offering amount: $50M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $16.5M Reported outside-investor minimum
- First sale
- Sep 24, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 10, 2024 | Initial | $50,000,016 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-526384
Source: Form D, filed Oct 10, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tomasz Dabrowski | Director, Executive |
| Grzegorz Dzik | Director |
| Kazimierz Herba | Director |
| Bartosz Jozefiak | Executive |
| Rohan Nirody | Director |
Issuer details
Industry: Other (See others in industry)
Address:
9650 Strickland Road, Suite 103 150
Raleigh, NC, 27615
Raleigh, NC, 27615